2025 themes for pricing and access success for rare disease and oncology medicines
Richard Sear, Emilie Neez, Richard Dutton
January 2025
In this report, explore six themes Dolon believes will impact pricing and access success for rare disease and oncology medicines in 2025.
Theme 1: Rising pricing tension
Theme 2: Protectionist Policies
Theme 3: GLP-1 Wave
Theme 4: Oncology Crowding
Theme 5: JCA “Implementation Time”
Theme 6: AI and Efficiency
